Skip to main content
. 2023 Aug 30;25(10):1161–1174. doi: 10.1007/s11912-023-01443-z

Fig. 1.

Fig. 1

Adoptive cell therapies manufacturing process. For engineered ACT, PBMCs are obtained from autologous peripheral blood. CARs or TCRs are added through transduction. In the case of TILs, lymphocytes are obtained from tumor samples. T cells are expanded in vitro before being infused intravenously into the patients. Figure created with BioRender.com